CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,487
- in 1 filing, $122K under 10b5-1 plans
Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2023-06-15 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2022-06-22 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2022-01-04 | Salter Malcolm Director | Grant or award | +428 | $31.58 | $14K | 11,380 |
| 2021-12-17 | Salter Malcolm Director | Sale | −755 | $30.25 | $23K | 10,952 |
| 2021-11-19 | Salter Malcolm Director | Sale | −755 | $40.11 | $30K | 11,707 |
| 2021-10-15 | Salter Malcolm Director | Sale | −755 | $44.94 | $34K | 12,462 |
| 2021-10-04 | Salter Malcolm Director | Grant or award | +300 | $44.99 | $13K | 13,217 |
| 2021-09-17 | Salter Malcolm Director | Sale | −755 | $49.89 | $38K | 12,917 |
| 2021-08-20 | Salter Malcolm Director | Sale | −755 | $40.73 | $31K | 13,672 |
| 2021-07-16 | Salter Malcolm Director | Sale | −755 | $37.37 | $28K | 14,427 |
| 2021-07-02 | Salter Malcolm Director | Grant or award | +339 | $39.72 | $13K | 15,182 |
| 2021-06-18 | Salter Malcolm Director | Sale | −755 | $37.19 | $28K | 14,843 |
| 2021-06-15 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2021-05-21 | Salter Malcolm Director | Sale | −755 | $37.12 | $28K | 15,598 |
| 2021-04-05 | Salter Malcolm Director | Grant or award | +359 | $37.51 | $13K | 16,353 |
| 2020-10-06 | Salter Malcolm Director | Conversion | +11,856 | 11,856 | ||
| 2020-10-06 | Salter Malcolm Director | Conversion | +2,823 | 14,679 | ||
| 2020-10-06 | Salter Malcolm Director | Purchase | +1,315 | $19.00 | $25K | 15,994 |
| 2020-10-06 | Salter Malcolm Director | Conversion · Series A Preferred Stock | −100,000 | 0 |
Page 1 of 2 · 22 trades